Compact Ozone Sterilizer Eliminates Contaminants and Germs
The Ozilla from AMSBIO is a new high quality, purpose-built ozone gas generator. Measuring just 13 x 11 x 5 inches (32 x 28 x 13 cm), it will fit in most standard laboratory cell culture incubators, air incubators, cell culture hoods, PCR hoods, or any other environment where a sterile atmosphere is critical. Following simple operational instructions the Ozilla is able to completely eliminate airborne and surface contaminants and germs including bacteria, phage and fungus.
Ozone is the most powerful oxidative agent that occurs naturally. With its extra free radical oxygen molecule, ozone is able to destroy germs, viruses, and microbes that may cause surface or air contamination. Furthermore, ozone leaves no chemical residue typical of alternative detergent or synthetic cleaners, and if handled properly — by converting ozone back to oxygen molecules — it can be one of the most effective sterilizing tools. Ozone is a powerful and natural purifier, and now with the Ozilla Ozone Sterilizer, it is safer and easier than ever to use ozone gas for sterilizing and deodorizing lightly contaminated pipettes, pipette tips, gloves, plates, small instruments, and even personal items such as keys and glasses.
The Ozilla sterilizer is easy and safe to use, and has a novel "scrubbing" technology that removes all ozone gases at the end of each sterilization cycle, by converting ozone gas back to oxygen. As an added advantage, the Ozilla air sterilizer will leave your room or cabinet odor-free and smelling fresh, clean, and ready for your next usage.
With the Ozilla Ozone Sterilizer, there is no longer a need to spend substantial amounts of time and money to plan and deal with the complexity of chemical decontaminations. Other than negating the labor and time waste, the Ozilla device eliminates exposure to toxic chemicals, and removes the possibility of chemical residue accumulation.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance